Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 641

1.

Gene regulation by dietary microRNAs.

Zempleni J, Baier SR, Howard KM, Cui J.

Can J Physiol Pharmacol. 2015 Apr 14:1-6. [Epub ahead of print]

PMID:
26222444
2.

Older adults' preferences for colorectal cancer-screening test attributes and test choice.

Kistler CE, Hess TM, Howard K, Pignone MP, Crutchfield TM, Hawley ST, Brenner AT, Ward KT, Lewis CL.

Patient Prefer Adherence. 2015 Jul 15;9:1005-16. doi: 10.2147/PPA.S82203. eCollection 2015.

3.

Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study.

Wortley S, Tong A, Lancsar E, Salkeld G, Howard K.

BMC Med Inform Decis Mak. 2015 Jul 14;15:52. doi: 10.1186/s12911-015-0176-0.

4.

Nonclinical evaluation of the potential for mast cell activation by an erythropoietin analog.

Weaver JL, Boyne M, Pang E, Chimalakonda K, Howard KE.

Toxicol Appl Pharmacol. 2015 Jun 14. pii: S0041-008X(15)30017-X. doi: 10.1016/j.taap.2015.06.009. [Epub ahead of print]

PMID:
26079829
5.

SHIPi Enhances Autologous and Allogeneic Hematolymphoid Stem Cell Transplantation.

Fernandes S, Brooks R, Gumbleton M, Park MY, Russo CM, Howard KT, Chisholm JD, Kerr WG.

EBioMedicine. 2015 Mar 1;2(3):205-213.

6.

White coat hypertension: improving the patient-health care practitioner relationship.

Cobos B, Haskard-Zolnierek K, Howard K.

Psychol Res Behav Manag. 2015 May 2;8:133-41. doi: 10.2147/PRBM.S61192. eCollection 2015. Review.

7.

A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury.

Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald J, Checchia PA, Meyer K, Shanley TP, Quasney M, Hall M, Gedeit R, Freishtat RJ, Nowak J, Raj SS, Gertz S, Dawson E, Howard K, Harmon K, Lahni P, Frank E, Hart KW, Lindsell CJ.

Crit Care Med. 2015 Aug;43(8):1646-53. doi: 10.1097/CCM.0000000000001079.

PMID:
25962083
8.

Patients' and providers' perspectives of a polypill strategy to improve cardiovascular prevention in Australian primary health care: a qualitative study set within a pragmatic randomized, controlled trial.

Liu H, Massi L, Laba TL, Peiris D, Usherwood T, Patel A, Cass A, Eades AM, Redfern J, Hayman N, Howard K, Brien JA, Jan S.

Circ Cardiovasc Qual Outcomes. 2015 May;8(3):301-8. doi: 10.1161/CIRCOUTCOMES.115.001483. Epub 2015 May 5.

PMID:
25944629
9.

Research Priorities in CKD: Report of a National Workshop Conducted in Australia.

Tong A, Crowe S, Chando S, Cass A, Chadban SJ, Chapman JR, Gallagher M, Hawley CM, Hill S, Howard K, Johnson DW, Kerr PG, McKenzie A, Parker D, Perkovic V, Polkinghorne KR, Pollock C, Strippoli GF, Tugwell P, Walker RG, Webster AC, Wong G, Craig JC.

Am J Kidney Dis. 2015 Aug;66(2):212-22. doi: 10.1053/j.ajkd.2015.02.341. Epub 2015 May 2.

PMID:
25943716
10.

The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation.

Nguyen HT, Lim WH, Craig JC, Chapman JR, Lord SJ, Howard K, Wong G.

Transplantation. 2015 May;99(5):957-64. doi: 10.1097/TP.0000000000000697.

PMID:
25943234
11.

Funding and planning: what you need to know for starting or expanding a home hemodialysis program.

Howard K, McFarlane PA, Marshall MR, Eastwood DO, Morton RL.

Hemodial Int. 2015 Apr;19 Suppl 1:S23-42. doi: 10.1111/hdi.12243.

PMID:
25925821
12.

Patient and caregiver preferences for home dialysis-the home first study: a protocol for qualitative interviews and discrete choice experiments.

Walker RC, Morton RL, Tong A, Marshall MR, Palmer S, Howard K.

BMJ Open. 2015 Apr 15;5(4):e007405. doi: 10.1136/bmjopen-2014-007405.

13.

Albumin: the next-generation delivery technology.

Howard KA.

Ther Deliv. 2015 Mar;6(3):265-8. doi: 10.4155/tde.14.124. No abstract available.

14.

The application of RNAi-based treatments for inflammatory bowel disease.

Olesen MT, Ballarín-González B, Howard KA.

Drug Deliv Transl Res. 2014 Feb;4(1):4-18. doi: 10.1007/s13346-013-0156-9.

PMID:
25786614
15.

RNA interference-based therapeutics and diagnostics.

Peer D, Howard KA.

Drug Deliv Transl Res. 2014 Feb;4(1):1-2. doi: 10.1007/s13346-013-0182-7. No abstract available.

PMID:
25786612
16.

Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial.

Howard K, Hayes A, Cho Y, Cass A, Clarke M, Johnson DW.

Am J Kidney Dis. 2015 May;65(5):773-9. doi: 10.1053/j.ajkd.2014.12.017. Epub 2015 Mar 4.

PMID:
25746151
17.

Cost-effectiveness of a Home-Exercise Program Among Older People After Hospitalization.

Farag I, Howard K, Hayes AJ, Ferreira ML, Lord SR, Close JT, Vogler C, Dean CM, Cumming RG, Sherrington C.

J Am Med Dir Assoc. 2015 Jun 1;16(6):490-6. doi: 10.1016/j.jamda.2015.01.075. Epub 2015 Feb 18.

PMID:
25703448
18.

Community preferences for the allocation of donor organs for transplantation: a discrete choice study.

Howard K, Jan S, Rose JM, Wong G, Irving M, Tong A, Craig JC, Chadban S, Allen RD, Cass A.

Transplantation. 2015 Mar;99(3):560-7. doi: 10.1097/TP.0000000000000365.

PMID:
25700169
19.

Patient preferences for a polypill for the prevention of cardiovascular diseases.

Laba TL, Howard K, Rose J, Peiris D, Redfern J, Usherwood T, Cass A, Patel A, Jan S.

Ann Pharmacother. 2015 May;49(5):528-39. doi: 10.1177/1060028015570468. Epub 2015 Feb 13.

PMID:
25680761
20.

Effectiveness of a multifactorial intervention on preventing development of frailty in pre-frail older people: study protocol for a randomised controlled trial.

Fairhall N, Kurrle SE, Sherrington C, Lord SR, Lockwood K, John B, Monaghan N, Howard K, Cameron ID.

BMJ Open. 2015 Feb 9;5(2):e007091. doi: 10.1136/bmjopen-2014-007091.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk